Nephrol Dial Transplant (2001) 16: 1087
© 2001 European Renal Association-European Dialysis and Transplant Association
Letters
Severe methotrexate intoxication in a haemodialysis patient treated for rheumatoid arthritis
1 Department of Nephrology, Pitie-S
lpetriere Hospital, Paris, France
2 Clinique du Plateau, Bezons, France
Sir,
Methotrexate is extensively used in the treatment of neoplastic diseases. It is a folic acid antagonist that inhibits the dihydrofolate reductase involved in the synthesis of puric and pyrimidic bases [1]. Methotrexate is also used at low doses in the treatment of severe rheumatoid
Case.
Comment.
References
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Hammoudeh Infliximab treatment in a patient with rheumatoid arthritis on haemodialysis Rheumatology, March 1, 2006; 45(3): 357 - 359. [Full Text] [PDF] |
||||
![]() |
C. Basile, A. Montanaro, and A. Semeraro Should low-dose methotrexate therapy be prescribed to dialysis patients? Nephrol. Dial. Transplant., March 1, 2002; 17(3): 530 - 531. [Full Text] [PDF] |
||||

